Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.Charles River Laboratories (CRL) shares fell 1.29% to $228.22, underperforming the broader market as the S&P 500 and Dow Jones rose. CRL closed 4.05% below its 52-week high. While competitors Labcorp and Alnylam also declined, Bio-Techne rose. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) slid 1.29% to $228.22 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,572.40 and the Dow Jones Industrial Average rising 0.29% to 52,658.64.
Charles River Laboratories International Inc. closed 4.05% below its 52-week high of $237.86, which the company achieved on July 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Labcorp Holdings Inc. (LH) fell 1.34% to $271.99, Alnylam Pharmaceuticals Inc. (ALNY) fell 0.75% to $279.14, and Bio-Techne Corp. (TECH) rose 0.35% to $71.48.
Trading volume (860,585) remained 48,811 below its 50-day average volume of 909,396.
Data source: Dow Jones Market Data, FactSet. Data compiled July 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-15-26 1715ET